"Triazolam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Below are MeSH descriptors whose meaning is more general than "Triazolam".
Below are MeSH descriptors whose meaning is more specific than "Triazolam".
This graph shows the total number of publications written about "Triazolam" by people in this website by year, and whether "Triazolam" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Triazolam" by people in Profiles.
Seggio JA, Logan RW, Rosenwasser AM. Chronic ethanol intake modulates photic and non-photic circadian phase responses in the Syrian hamster. Pharmacol Biochem Behav. 2007 Aug-Sep; 87(3):297-305.
Matsumoto S, Basil J, Jetton AE, Lehman MN, Bittman EL. Regulation of the phase and period of circadian rhythms restored by suprachiasmatic transplants. J Biol Rhythms. 1996 Jun; 11(2):145-62.
Rothschild AJ. Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature. J Clin Psychiatry. 1992 Dec; 53 Suppl:69-79.